The Prognostic Role of Procalcitonin in Critically Ill Patients Admitted in a Medical Stepdown Unit: A Retrospective Cohort Study
暂无分享,去创建一个
V. Zaccone | L. Falsetti | A. Marchetti | A. Salvi | C. Nitti | Mattia Sampaolesi | Francesca Riccomi | T. Gentili | Maria‐Novella Piersantelli | Alessia Raponi
[1] M. Okano,et al. Cohort Study , 2020, Definitions.
[2] S. Goldberg,et al. Cardiogenic Shock , 2019, Journal of the American Heart Association.
[3] T. Osborn,et al. Sepsis in the older person: The ravages of time and bacteria , 2018, Emergency medicine Australasia : EMA.
[4] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[5] Michel Wolff,et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2017, The Cochrane database of systematic reviews.
[6] T. Walsh,et al. Early troponin I in critical illness and its association with hospital mortality: a cohort study , 2017, Critical Care.
[7] Ashitha L. Vijayan,et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy , 2017, Journal of Intensive Care.
[8] S. Gin,et al. Standing the test of time , 2017, Nature.
[9] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[10] L. Su,et al. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis , 2015, PloS one.
[11] K. Werdan,et al. Kardiogener Schock , 2014, Deutsche Medizinische Wochenschrift.
[12] H. Wunsch,et al. The role of stepdown beds in hospital care. , 2014, American journal of respiratory and critical care medicine.
[13] Fiona Lecky,et al. The Glasgow Coma Scale at 40 years: standing the test of time , 2014, The Lancet Neurology.
[14] T. van der Poll,et al. Severe sepsis and septic shock. , 2013, The New England journal of medicine.
[15] Peter Schlattmann,et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.
[16] J. Dekker,et al. Promising new assays and technologies for the diagnosis and management of infectious diseases. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Jensen,et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality* , 2006, Critical care medicine.
[18] M. Meisner,et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications , 2002, Intensive Care Medicine.
[19] C. Subbe,et al. Validation of a modified Early Warning Score in medical admissions. , 2001, QJM : monthly journal of the Association of Physicians.
[20] G. Ricevuti,et al. Plasma Levels of Procalcitonin and Interleukin-6 in Acute Myocardial Infarction , 2001, Inflammation.
[21] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .
[22] D M Linton,et al. Severity of disease classification system. , 1991, Critical care medicine.
[23] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[24] M. Al-Haddad,et al. Recognizing the critically ill patient , 2013 .
[25] J. Vincent,et al. Circulatory shock. , 2013, The New England journal of medicine.
[26] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.